785 related articles for article (PubMed ID: 26169892)
1. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
3. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
Heining L; Giesa C; Ewig S
Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
[TBL] [Abstract][Full Text] [Related]
4. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Neath SX; Landsberg J; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Möckel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Christenson RH; Potocki M; McCord J; Terracciano G; Hartmann O; Bergmann A; Morgenthaler NG; Anker SD
Eur J Heart Fail; 2012 Mar; 14(3):278-86. PubMed ID: 22302662
[TBL] [Abstract][Full Text] [Related]
5. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
6. The value of procalcitonin level in community-acquired pneumonia in the ED.
Park JH; Wee JH; Choi SP; Oh SH
Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M
BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562
[TBL] [Abstract][Full Text] [Related]
8. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
9. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
[TBL] [Abstract][Full Text] [Related]
10. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department.
Hausfater P; Juillien G; Madonna-Py B; Haroche J; Bernard M; Riou B
Crit Care; 2007; 11(3):R60. PubMed ID: 17521430
[TBL] [Abstract][Full Text] [Related]
11. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea.
Collins SP; Peacock WF; Lindsell CJ; Clopton P; Diercks DB; Hiestand B; Hogan C; Kontos MC; Mueller C; Nowak R; Chen WJ; Huang CH; Abraham WT; Amsterdam E; Breidthardt T; Daniels L; Hasan A; Hudson M; McCord J; Naz T; Wagoner LE; Maisel A
Ann Emerg Med; 2009 Jun; 53(6):748-57. PubMed ID: 19232777
[TBL] [Abstract][Full Text] [Related]
12. Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.
de Kruif MD; Limper M; Gerritsen H; Spek CA; Brandjes DP; ten Cate H; Bossuyt PM; Reitsma PH; van Gorp EC
Crit Care Med; 2010 Feb; 38(2):457-63. PubMed ID: 20083920
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection.
Dörge H; Schöndube FA; Dörge P; Seipelt R; Voss M; Messmer BJ
Thorac Cardiovasc Surg; 2003 Dec; 51(6):322-6. PubMed ID: 14669128
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin variations after Emergency Department admission are highly predictive of hospital mortality in patients with acute infectious diseases.
Magrini L; Travaglino F; Marino R; Ferri E; De Berardinis B; Cardelli P; Salerno G; Di Somma S
Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():133-42. PubMed ID: 23436675
[TBL] [Abstract][Full Text] [Related]
18. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department.
Magrini L; Gagliano G; Travaglino F; Vetrone F; Marino R; Cardelli P; Salerno G; Di Somma S
Clin Chem Lab Med; 2014 Oct; 52(10):1465-72. PubMed ID: 24803611
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic properties of procalcitonin in patients with acute dyspnea: Data from the ACE 2 Study.
Berge K; Lyngbakken MN; Einvik G; Winther JA; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
Clin Biochem; 2018 Sep; 59():62-68. PubMed ID: 30028971
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.
Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B
Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
